Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
Completed
- Conditions
- Refractory Ascites
- Registration Number
- NCT06196723
- Lead Sponsor
- Tang-Du Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 462
Inclusion Criteria
Inclusion Criteria:<br><br>Definite diagnosis of recurrent ascites in cirrhosis (based on clinical symptoms,<br>laboratory and imaging studies, or liver biopsy) TIPS or LVP+A therapy, -<br><br>Exclusion Criteria:<br><br>Malignant neoplasm, including hepatocellular carcinoma with extrahepatic metastasis Prior<br>liver transplantation Severe heart and lung dysfunction Recurrent hepatic encephalopathy<br>Concomitant active infection TIPS with the use of uncovered stents Complete portal vein<br>thrombosis<br><br>
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method One year transplant free survival
- Secondary Outcome Measures
Name Time Method